These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


347 related items for PubMed ID: 10763821

  • 1. Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells.
    Neve RM, Sutterlüty H, Pullen N, Lane HA, Daly JM, Krek W, Hynes NE.
    Oncogene; 2000 Mar 23; 19(13):1647-56. PubMed ID: 10763821
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
    Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B.
    EMBO J; 1996 Dec 02; 15(23):6595-604. PubMed ID: 8978686
    [Abstract] [Full Text] [Related]

  • 5. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
    Tsihlias J, Zhang W, Bhattacharya N, Flanagan M, Klotz L, Slingerland J.
    Oncogene; 2000 Feb 03; 19(5):670-9. PubMed ID: 10698512
    [Abstract] [Full Text] [Related]

  • 6. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S, Lowe M, Herliczek TW, Keyomarsi K.
    Oncogene; 1998 Nov 05; 17(18):2393-402. PubMed ID: 9811471
    [Abstract] [Full Text] [Related]

  • 7. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM, Dickson RB.
    Oncogene; 2001 Jul 27; 20(33):4554-67. PubMed ID: 11494151
    [Abstract] [Full Text] [Related]

  • 8. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang LS.
    Exp Cell Res; 2000 Aug 25; 259(1):35-53. PubMed ID: 10942577
    [Abstract] [Full Text] [Related]

  • 9. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest.
    Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, Franssen E, Slingerland JM.
    Nat Med; 2002 Oct 25; 8(10):1153-60. PubMed ID: 12244302
    [Abstract] [Full Text] [Related]

  • 10. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J.
    Oncogene; 2000 Nov 09; 19(47):5314-23. PubMed ID: 11103932
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov 09; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 12. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells.
    Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y.
    J Cell Biochem; 1999 Sep 01; 74(3):486-98. PubMed ID: 10412049
    [Abstract] [Full Text] [Related]

  • 13. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
    Cereseto A, Washington Parks R, Rivadeneira E, Franchini G.
    Oncogene; 1999 Apr 15; 18(15):2441-50. PubMed ID: 10229195
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Investigation of the cell cycle regulation of cdk3-associated kinase activity and the role of cdk3 in proliferation and transformation.
    Braun K, Hölzl G, Soucek T, Geisen C, Möröy T, Hengstschläger M.
    Oncogene; 1998 Oct 29; 17(17):2259-69. PubMed ID: 9811456
    [Abstract] [Full Text] [Related]

  • 16. ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency.
    Lane HA, Beuvink I, Motoyama AB, Daly JM, Neve RM, Hynes NE.
    Mol Cell Biol; 2000 May 29; 20(9):3210-23. PubMed ID: 10757805
    [Abstract] [Full Text] [Related]

  • 17. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M, Estanyol JM, Serratosa J, Agell N, Bachs O.
    Hepatology; 1999 Feb 29; 29(2):385-95. PubMed ID: 9918914
    [Abstract] [Full Text] [Related]

  • 18. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event.
    Zancai P, Cariati R, Rizzo S, Boiocchi M, Dolcetti R.
    Oncogene; 1998 Oct 08; 17(14):1827-36. PubMed ID: 9778049
    [Abstract] [Full Text] [Related]

  • 19. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
    Nahum A, Hirsch K, Danilenko M, Watts CK, Prall OW, Levy J, Sharoni Y.
    Oncogene; 2001 Jun 07; 20(26):3428-36. PubMed ID: 11423993
    [Abstract] [Full Text] [Related]

  • 20. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Orend G, Hunter T, Ruoslahti E.
    Oncogene; 1998 May 07; 16(20):2575-83. PubMed ID: 9632134
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.